Targeted deletion of regions rich in immune-evasive genes from the cytomegalovirus genome as a novel vaccine strategy.
about
Murine Cytomegalovirus Deubiquitinase Regulates Viral Chemokine Levels To Control Inflammation and PathogenesisA spread-deficient cytomegalovirus for assessment of first-target cells in vaccination.A novel murine cytomegalovirus vaccine vector protects against Mycobacterium tuberculosis.Degradation of cellular mir-27 by a novel, highly abundant viral transcript is important for efficient virus replication in vivo.Herpesvirus BACs: past, present, and future.Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases.Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.Can we build it better? Using BAC genetics to engineer more effective cytomegalovirus vaccines.Cytomegalovirus infection impairs immune responses and accentuates T-cell pool changes observed in mice with aging.An adjuvanted inactivated murine cytomegalovirus (MCMV) vaccine induces potent and long-term protective immunity against a lethal challenge with virulent MCMVActivation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D LigandA live guinea pig cytomegalovirus vaccine deleted of three putative immune evasion genes is highly attenuated but remains immunogenic in a vaccine/challenge model of congenital cytomegalovirus infection.Update on the current status of cytomegalovirus vaccines.An attenuated cytomegalovirus vaccine with a deletion of a viral chemokine gene is protective against congenital CMV transmission in a guinea pig modelThe impact of genome length on replication and genome stability of the herpesvirus guinea pig cytomegalovirusCongenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis.An Attenuated CMV Vaccine with a Deletion in Tegument Protein GP83 (pp65 Homolog) Protects against Placental Infection and Improves Pregnancy Outcome in a Guinea Pig Challenge Model.Cytomegalovirus and varicella-zoster virus vaccines in hematopoietic stem cell transplantation.Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?Interplay between CMVs and interferon signaling: implications for pathogenesis and therapeutic intervention.MCMV avoidance of recognition and control by NK cells.CMV immune evasion and manipulation of the immune system with aging.
P2860
Q28468563-3351D1AA-91A9-47A1-85BF-8FAFAAD401D9Q33964131-EE646BA9-5193-48E0-9C40-3DC02A287A8CQ34053500-CDAC4297-DEEC-405D-B6A5-016B90912C16Q34162259-65AF6DAB-3BA6-40D4-9CA5-CC6F4A7BEAE9Q34247863-F1754C2F-84F8-4EE0-8776-D234E522CE04Q34349745-9D55F46A-D201-498D-BB10-3E5DD41B23BCQ34360228-30195B6A-3C47-463E-98C6-192A2E6B3DA2Q34360247-472DA768-3C26-4B6A-8BB6-9F0D89079EDEQ34390499-EA4EC3DC-3331-42CF-AB40-5A7AF850EC0DQ35144633-A28B697D-3A42-43FD-B178-0E42992F87CBQ36210368-AF971C79-DAC6-444D-A317-323A90F3A687Q36517130-32682E29-9494-4137-8F49-5C17094A64F1Q36678423-E9F81675-2244-4B86-BFDC-314317A3109DQ37127280-4CD29B11-4336-4B41-A2FC-5E5A10E47C6DQ37221270-B36DDC62-CCD6-4481-90AA-C88FB87ABD08Q37406553-353C6740-5263-4EE6-A092-E989318EF253Q37508272-DA0656E5-E128-41BC-827C-AA9B37C63402Q37559627-006A86F4-54FC-40E8-AB2E-9EC463854DEAQ37574334-67823AAF-D2BD-44F2-9515-63D09A6D78C0Q38052946-397F6859-2A4B-4EB2-9113-429313EBF298Q38241668-2F80ABCE-89C2-4D85-986F-ED6AA9ACC000Q55459013-8509DEB4-8607-4464-A039-DF2179FC91EB
P2860
Targeted deletion of regions rich in immune-evasive genes from the cytomegalovirus genome as a novel vaccine strategy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Targeted deletion of regions r ...... e as a novel vaccine strategy.
@ast
Targeted deletion of regions r ...... e as a novel vaccine strategy.
@en
type
label
Targeted deletion of regions r ...... e as a novel vaccine strategy.
@ast
Targeted deletion of regions r ...... e as a novel vaccine strategy.
@en
prefLabel
Targeted deletion of regions r ...... e as a novel vaccine strategy.
@ast
Targeted deletion of regions r ...... e as a novel vaccine strategy.
@en
P2093
P2860
P356
P1433
P1476
Targeted deletion of regions r ...... me as a novel vaccine strategy
@en
P2093
Christian Mohr
Ivan Bubić
Margit Schnee
Ulrich H Koszinowski
Zsolt Ruzsics
P2860
P304
13825-13834
P356
10.1128/JVI.01911-07
P407
P577
2007-10-03T00:00:00Z